معرفی
Professor Jules Griffin is Director of the Rowett Institute at the University of Aberdeen and holds a professorship in the School of Medicine, Medical Sciences and Nutrition. An internationally recognized leader in metabolomics and lipidomics, his research focuses on metabolic diseases, nutrition interactions, and the biochemical mechanisms of lipid dysfunction. Previously, he held the Chair of Biological Chemistry at Imperial College London (2019-2021) and served as Programme Leader at MRC Human Nutrition Research/University of Cambridge (2011-2019).
Education includes a D.Phil. in Biochemistry from the University of Oxford, with postdoctoral training at Harvard Medical School/Massachusetts General Hospital and Imperial College London. His research program spans:
- Development of high-throughput metabolomics/lipidomics platforms
- Mechanistic studies of metabolic syndrome using cellular, animal and human models
- Population-level nutrition assessment through metabolic phenotyping
- Mass spectrometry imaging of tissue metabolism
- Genome-scale metabolic reconstructions
Research focuses on lipid metabolism in cardiometabolic diseases (NAFLD, diabetes, heart failure) and neurodegeneration. Recent publications demonstrate strong emphasis on:
- Lipidomics in disease mechanisms and exercise interventions
- Metabolic adaptations to nutritional interventions
- Multi-omics integration for disease subtyping
- Methodological advances in mass spectrometry
- Translational applications in clinical nutrition
Honors include:
- Trapnell Research Fellowship, King's College Cambridge (2003-2007)
- Agilent Thought Leader Award (2016)
- Fellowship of the Royal Society of Chemistry
- Former President, Metabolomics Society (2016-2020)
- Honorary Professor, Imperial College London (2022-present)
- Visiting Professorships at University of Cagliari, Italy
Directs the Rowett Institute with extensive collaborations including UK Consortium on Metabolic Phenotyping. Currently accepting PhD students in Nutrition and Health. Editorial board member for Genome Medicine and Metabolites.
